Knoxville Kidney Center, Pllc

CLIA Laboratory Citation Details

2
Total Citations
4
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 44D1054252
Address 320 Park 40 North Blvd, Suite A, Knoxville, TN, 37923
City Knoxville
State TN
Zip Code37923
Phone865 692-3462
Lab DirectorGEORGE NEWMAN

Citation History (2 surveys)

Survey - May 14, 2024

Survey Type: Standard

Survey Event ID: 6BO111

Deficiency Tags: D5401

Summary:

Summary Statement of Deficiencies D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on observation of two laboratory rooms, a review of the laboratory's policy, a review of the manufacturer's cassette package, and an interview with the clinic manager, the laboratory failed to follow its written policy for documenting open and "open vial" expiration dates for 65 i-STAT CHEM8+ test cartridges observed on the survey date (05.14.2024). The findings include: 1. Observation of the two laboratory rooms on 05.14.2024 at 9:00 a.m. revealed two Abbott iSTAT instruments (serial numbers 434284 and 397786) in laboratory room #2 and one Abbott iSTAT instrument (serial number 416818) in laboratory room #3 in use for patient testing for Sodium, Potassium, Chloride, Total Carbon Dioxide, Ionized Calcium, Glucose, Urea Nitrogen, Creatinine, and Hematocrit using the CHEM8+ test cartridge. Also observed were 31 CHEM8+ test cartridges (lot number H24068) stored at room temperature on the counter in laboratory room #2 and 34 CHEM8+ test cartridges (lot number H24068) stored at room temperature on the counter in laboratory room #3 not labeled with open or revised expiration dates. 2. A review of the laboratory's policy titled "Reagent Management" section "IV. Utilization" revealed the statement "Date all reagents, etc., when opened. Also documented the "open vial" expiration date on the container." 3. A review of the manufacturer's cassette package revealed that CHEM8+ cassettes can be stored for 14 days at room temperature (18C-30C). 4. An interview with the clinic manager on 05.14.2024 at 9:03 a.m. confirmed the laboratory Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- failed to follow its written policy for documenting open and "open vial" expiration dates for 65 i-STAT CHEM8+ test cartridges observed on the survey date (05.14.2024). Word Key: C = degrees Celsius -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - April 12, 2022

Survey Type: Standard

Survey Event ID: 4QK611

Deficiency Tags: D2009 D2007 D5445

Summary:

Summary Statement of Deficiencies D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: ==================================== Based on review of the laboratory's American Proficiency Institute (API) proficiency testing (PT) records, the Centers for Medicare and Medicaid Services form 209 Laboratory Personnel Report (CMS-209) and interview with the laboratory practice administrator, the laboratory failed to test proficiency testing samples by routine testing personnel in 2020 and 2021. The finding include: 1. Review of the laboratory's PT records revealed that testing personnel number four performed four of four chemistry PT events (2020 event three; 2021 events one, two, and three). 2. Review of the CMS-209 revealed six personnel who perform patient testing. 3. Interview with the pactice administrator on April 12, 2022 at 12:30 pm confirmed that testing personnel number four performed four of four PT events for 2020 and 2021. The laboratory failed to test proficiency testing samples by the same personnel who perform patient testing in 2020 and 2021. ==================================== D2009 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The individual testing or examining the samples and the laboratory director must attest to the routine integration of the samples into the patient workload using the laboratory's routine methods. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: =================================== Based on review of the laboratory's American Proficiency Institute (API) proficiency testing (PT) records, the Centers for Medicare and Medicaid Services form 209 Laboratory Personnel Report (CMS-209) and interview with the laboratory practice administrator, it was determined the testing personnel failed to sign the attestation sheets for chemistry PT for 2020, 2021, and 2022. The findings include: 1. Review of the laboratory's PT records revealed that attestation sheets were not signed by testing personnel for five of five chemistry PT events (2020 event three; 2021 events one, two, and three; 2022 event one). 2. Interview with the pactice administrator on April 12, 2022 at 12:30 pm confirmed that attestation sheets were not signed by testing personnel for five of five chemistry PT events (2020 event three; 2021 events one, two, and three; 2022 event one). ================================== D5445 CONTROL PROCEDURES CFR(s): 493.1256(d)(1)(2)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- (d)(1) Perform control procedures as defined in this section unless otherwise specified in the additional specialty and subspecialty requirements at 493.1261 through 493.1278. (d)(2) For each test system, perform control procedures using the number and frequency specified by the manufacturer or established by the laboratory when they meet or exceed the requirements in paragraph (d)(3) of this section. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: ================================== Based on review of the quality control (QC) and patient records, lack of an Individualized Quality Control Plan (IQCP), and interview with the practice administrator, the laboratory failed to perform QC each day of patient testing or develop and implement an IQCP prior to March 12, 2020, for the iSTAT analyzers. The findings include: 1. Review of the QC and patient records revealed iSTAT QC performed when new lots of cartridges were started. 2. No IQCP was available for review at the time of survey on April 12, 2022. 3. Interview on April 12, 2022 at 12:30 p.m. with the practice administrator confirmed the laboratory does not perform QC daily with patient testing but follows the manufacturer's instructions for performance of QC frequency and does not have an IQCP in place for the iSTAT analyzer. ================================== -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access